The Daily Dose – Researchers 2, Ebola 0
Today’s dose settles the score with Ebola virus. The fight continues, however, over Johnson & Johnson, the European debt crisis, and spreading flu. Read more
Today’s dose settles the score with Ebola virus. The fight continues, however, over Johnson & Johnson, the European debt crisis, and spreading flu. Read more
A couple years ago, my mother didn’t want clothes, jewelry, or even a day at the spa for Christmas. She wanted a Nintendo Wii. Video games? Are you kidding me? No, she wasn’t. She specifically wanted Wii Fit, the game where you can do yoga and other exercises on a balancing board, and though my brother and I were skeptical, we granted her wish. A few months later, the machine was collecting dust. It’s a story I like to remind my mother about every once in a while, especially when I go back to visit. (My 20 minutes of MarioKart … Read more
Today’s dose is adding up the numbers on condom use, cancer mutations, and clinical trials. There’s also some suspicion over supplements. Read more
The field of guidance documents for human embryonic stem cell research seems like it’ll be getting a little smaller. The National Academies released an updated set of guidelines today, but the committee behind the document has decided to disband. In its report, the Human Embryonic Stem Cell Research Advisory Committee (HESCRAC) says that guidance put out by the National Institutes of Health should now supersede its own. Read more
In today’s dose, there’s news on medical marijuana, open-source research, fat across the sexes, and a new FDA partnership. Read more
There was a sense of relief yesterday at a New York Academy of Sciences conference on H1N1. Nearly a year before, many of the same people had gathered to discuss the emerging swine flu pandemic; this year, they’re catching their breath. The speakers, however, didn’t mince their words when it came to the need to bolster pandemic preparedness. Read more
If blood and death make you uneasy, be careful with today’s dose. Skip to the end, which has FDA news. Read more
Monday’s dose is a barometer for what’s ahead. There’s split opinion on the FDA, a thumbs up for research from the Vatican, and a possible ‘NICE’ softening in the UK. Read more
Yesterday doesn’t seem so far away when there are updates right in front of you. Here’s the latest on a few stories we’ve been following. Read more
The science world is buzzing today over a study in Science, announcing the successful creation of an entirely synthetic genome. Researchers at the J. Craig Venter Institute in Rockville, Maryland inserted a complete DNA sequence into an emptied bacterial cell to form what some are calling artificial life. While the implications for genetics, evolution, and the very philosophy of life are already garnering debate, medicine might also enter the fray. The proper use of this new technology could yield, for example, therapeutic bacteria. University of Pennsylvania bioethicist Arthur Caplan comments on MSNBC that synthetic bacteria could be created to go … Read more
Recent comments
Real-time tissue analysis could guide brain tumor surgery
Bundled RNA balls silence brain cancer gene expression
Ebola outbreak in West Africa lends urgency to recently-funded research